Silverfin false 31/03/2024 21/03/2023 31/03/2024 Dr Nandish Jayappa 21/03/2023 Dr Fabian Lee 21/03/2023 Dr Emma Wade 21/03/2023 20 January 2025 SO307749 2024-03-31 SO307749 bus:Director1 2024-03-31 SO307749 bus:Director2 2024-03-31 SO307749 bus:Director3 2024-03-31 SO307749 core:CurrentFinancialInstruments 2024-03-31 SO307749 core:OtherPropertyPlantEquipment 2023-03-20 SO307749 2023-03-20 SO307749 core:OtherPropertyPlantEquipment 2024-03-31 SO307749 2023-03-21 2024-03-31 SO307749 bus:FullAccounts 2023-03-21 2024-03-31 SO307749 bus:SmallEntities 2023-03-21 2024-03-31 SO307749 bus:AuditExemptWithAccountantsReport 2023-03-21 2024-03-31 SO307749 bus:LimitedLiabilityPartnershipLLP 2023-03-21 2024-03-31 SO307749 bus:Director1 2023-03-21 2024-03-31 SO307749 bus:Director2 2023-03-21 2024-03-31 SO307749 bus:Director3 2023-03-21 2024-03-31 SO307749 core:OtherPropertyPlantEquipment 2023-03-21 2024-03-31 iso4217:GBP xbrli:pure

Company No: SO307749 (Scotland)

WESTBURN MEDICAL GROUP LLP

Unaudited Financial Statements
For the financial period from 21 March 2023 to 31 March 2024
Pages for filing with the registrar

WESTBURN MEDICAL GROUP LLP

Unaudited Financial Statements

For the financial period from 21 March 2023 to 31 March 2024

Contents

WESTBURN MEDICAL GROUP LLP

BALANCE SHEET

As at 31 March 2024
WESTBURN MEDICAL GROUP LLP

BALANCE SHEET (continued)

As at 31 March 2024
Note 31.03.2024
£
Fixed assets
Tangible assets 3 11,392
11,392
Current assets
Debtors 4 4,878
Cash at bank and in hand 58,974
63,852
Creditors: amounts falling due within one year 5 ( 42,574)
Net current assets 21,278
Total assets less current liabilities 32,670
Net assets attributable to members 32,670
Represented by
Loans and other debts due to members within one year
Other amounts 32,670
32,670
Members' other interests
0
32,670
Total members' interests
Loans and other debts due to members 32,670
32,670

For the financial period ending 31 March 2024 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

Members' responsibilities:

Westburn Medical Group LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Westburn Medical Group LLP (registered number: SO307749) were approved and authorised for issue by the Board of Directors on 20 January 2025. They were signed on its behalf by:

Dr Nandish Jayappa
Designated member
Dr Fabian Lee
Designated member
Dr Emma Wade
Designated member
WESTBURN MEDICAL GROUP LLP

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 21 March 2023 to 31 March 2024
WESTBURN MEDICAL GROUP LLP

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 21 March 2023 to 31 March 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Westburn Medical Group LLP is a limited liability partnership, incorporated in the United Kingdom under the Limited Liability Partnerships Act 2000 and is registered in Scotland. The address of the LLP's registered office is Foresterhill Health Centre, Aberdeen Royal Infirmary, Foresterhill Road, Aberdeen, AB25 2XE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Limited Liability Partnerships Act 2000 as applicable to companies subject to the small companies regime and the requirements of the Statement of Recommended Practice Accounting by Limited Liability Partnerships issued in December 2021 (SORP 2022).

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

At the time of approving the financial statements, the members have a reasonable expectation that the LLP has adequate resources to continue in operational existence for at least twelve months from the date of signing the financial statements. Thus the members have continued to adopt the going concern basis of accounting in preparing the financial statements.

Turnover

Turnover represents amounts earned during the period from the provision of medical services.

If, at the Balance sheet date, completion of contractual obligations is dependent on external factors (and thus outside the control of the Limited Liability Partnership), then revenue is recognised only when the event occurs. In such cases, partner and employee time incurred up to the Balance sheet date are carried forward as work in progress.

Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised as an expense when the LLP is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Defined contribution schemes
The LLP operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial period. Differences between contributions payable in the financial period and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

The taxation payable on the partnership's profits is the personal liability of the members, although payment of such liabilities is administered by the partnership on behalf of its members. Consequently, neither partnership taxation nor related deferred taxation is accounted for in these financial statements. Sums set aside in respect of members' tax obligations are included in the balance sheet within loans and other debts due to members, or are set against amounts due from members as appropriate.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 7 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The LLP as lessee
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Non-financial assets
At each balance sheet date, the LLP reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Members' participation rights

Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).

Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A member's participation rights including amounts subscribed or otherwise contributed by members, for example members' capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to members, in which case they are classified as equity.

Other amounts applied to members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment. Amounts payable to members under employment contracts and unavoidable interest on members capital are charged to “members remuneration charged as an expense” in the relevant year.

Provisions

Provisions are recognised when the LLP has a present obligation (legal or constructive) as a result of a past event, it is probable that the LLP will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

Period from
21.03.2023 to
31.03.2024
Number
Monthly average number of persons employed by the LLP during the period 14

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 21 March 2023 0 0
Additions 12,150 12,150
At 31 March 2024 12,150 12,150
Accumulated depreciation
At 21 March 2023 0 0
Charge for the financial period 758 758
At 31 March 2024 758 758
Net book value
At 31 March 2024 11,392 11,392

4. Debtors

31.03.2024
£
Other debtors 4,878

5. Creditors: amounts falling due within one year

31.03.2024
£
Trade creditors 17,975
Other taxation and social security 6,344
Other creditors 18,255
42,574